Analysis of influencing factors for metabolic surgery treating overweight or obesity Short-term efficacy

doi:10.3877/cma.j.issn.2095-9605.2017.03.005

Abstract

Abstract:

Objective

To explore the influencing factors on weight loss of metabolic surgery to improve the understanding of metabolic surgery.

Methods

The clinical data of 83 patients who underwent metabolic surgery from Jan. 2008 to Jun. 2016 in Jiahe Surgical Hospital were analyzed retrospectively. Weight and BMI were observed before and at 12 months after operation.

Results

A total of 80 patients completed a 1-year follow-up. Postoperative patients with body weight and BMI showed a downward trend (P<0.05) , and weight loss is more obvious in patients who have lower waist-to-height ratio (P<0.05) , but there was no significant difference in age, sex, surgery approaches, whether with diabetes mellitus, body mass index, and waist-to-hip ratio.

Conclusions

Metabolic surgery can significantly reduce the weight of obese patients, and patients who have lower waist-to-height ratio will get more weight loss.

Key words: Obesity, Metabolic surgery, Weight loss

Didi Zuo, Chao Li, Guixia Wang, Mingxing Ding. Analysis of influencing factors for metabolic surgery treating overweight or obesity Short-term efficacy[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2017, 03(03): 133-137.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2017.03.005

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2017/V03/I03/133

Figures/Tables 3

References 36

[1]	Jiang N, Yu H, An R. Body weight status and health-care expenditure among university retirees in Beijing, China[J]. Australas J Ageing, 2017. 36(Suppl.1).
[2]	He Y, Pan A, Wang Y, et al. Prevalence of overweight and obesity in 15.8 million men aged 15-49 years in rural China from 2010 to 2014[J]. Sci Rep, 2017, 7(1):5012.
[3]	Zhang Y X, Wang S R, Chen M, et al. Recent Trends in Body Mass Index and Waist Circumference among Children and Adolescents in Shandong China[J]. J Trop Pediatr, 2017.
[4]	Song P, Yu J, Chang X, et al. Prevalence and Correlates of Metabolic Syndrome in Chinese Children: The China Health and Nutrition Survey[J]. Nutrients, 2017, 9(1):79.
[5]	Arterburn D E, Olsen M K, Smith V A, et al. Association between bariatric surgery and long-term survival[J]. JAMA, 2015, 313(1):62-70.
[6]	Schauer P R, Bhatt D L, Kirwan J P, et al. Bariatric surgery versus intensive medical therapy for diabetes:3-year outcomes[J]. N Engl J Med, 2014, 370(21):2002-2013.
[7]	Fernandez-Soto M L, Martin-Leyva A, Gonzalez-Jimenez A, et al. Remission of type 2 diabetes mellitus after bariatric surgery- comparison between procedures[J]. Endokrynol Pol, 2017, 68(1):18-25.
[8]	刘金刚，郑成竹，王勇. 中国肥胖和2型糖尿病外科治疗指南(2014)[J]. 中国实用外科杂志, 2014(11):1005-1010.
[9]	Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI 28 kg/m²: a multi-institutional study[J]. J Biomed Res, 2015, 29(2):112-117.
[10]	Association. A D. Standards of medical care in diabetes 2012[J]. Diabetes Care, 2012, 35 Suppl 1:S11-S63.
[11]	方登华，李滢旭，余雄武, 等. 腹腔镜袖状胃切除术治疗单纯性肥胖症的短期疗效观察[J]. 中华肥胖与代谢病电子杂志, 2015 (01):26-29.
[12]	郑成竹，柯重伟，印慨, 等. 腹腔镜垂直捆绑胃成形术治疗病态肥胖(附25例报告)[J]. 中国实用外科杂志, 2002(10):17-19.
[13]	Buchwald H, Oien D M. Metabolic/bariatric surgery worldwide 2011[J]. Obes Surg, 2013, 23(4):427-436.
[14]	Al-Khyatt W, Ryall R, Leeder P, et al. Predictors of Inadequate Weight Loss After Laparoscopic Gastric Bypass for Morbid Obesity[J]. Obes Surg, 2017, 27(6):1446-1452.
[15]	Chikunguwo S M, Wolfe L G, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass[J]. Surg Obes Relat Dis, 2010, 6(3):254-259.
[16]	Thereaux J, Lesuffleur T, Paita M, et al. Long-term follow-up after bariatric surgery in a national cohort[J]. Br J Surg, 2017, 104(10): 1362-1371.
[17]	Leyba J L, Llopis S N, Aulestia S N. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. a prospective study with 5 years of follow-up[J]. Obes Surg, 2014, 24(12):2094-2098.
[18]	Zhang N, Maffei A, Cerabona T, et al. Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy[J]. Surg Endosc, 2013, 27(4):1273-1280.
[19]	Fernandez-Soto M L, Martin-Leyva A, Gonzalez-Jimenez A, et al. Remission of type 2 diabetes mellitus after bariatric surgery- comparison between procedures[J]. Endokrynol Pol, 2017, 68(1):18-25.
[20]	Fernandez-Soto M L, Martin-Leyva A, Gonzalez-Jimenez A, et al. Remission of type 2 diabetes mellitus after bariatric surgery- comparison between procedures[J]. Endokrynol Pol, 2017, 68(1):18-25.
[21]	Perrone F, Bianciardi E, Ippoliti S, et al. Long-term effects of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of morbid obesity: a monocentric prospective study with minimum follow-up of 5 years[J]. Updates Surg, 2017,69(1):101-107.
[22]	Li J F, Lai D D, Lin Z H, et al. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials[J]. Surg Laparosc Endosc Percutan Tech, 2014,24(1):1-11.
[23]	Li J, Lai D, Wu D. Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis[J]. Obes Surg, 2016, 26(2):429-442.
[24]	Angrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery Worldwide 2013[J]. Obes Surg, 2015, 25(10):1822-1832.
[25]	刘金钢. 中国肥胖及2型糖尿病手术治疗的现状与未来[J]. 中国糖尿病杂志, 2015(09):773-775.
[26]	Zhang Y X, Wang Z X, Chu Z H, et al. Blood pressure profiles of children and adolescents categorized by waist-to-height ratio cutoffs: study in a large sample in Shandong, China[J]. Blood Press Monit, 2017, 22(3):143-148.
[27]	Stevens J, Katz E G, Huxley R R. Associations between gender, age and waist circumference[J]. Eur J Clin Nutr, 2010,64(1):6-15.
[28]	Zimmet P, Magliano D, Matsuzawa Y, et al. The metabolic syndrome: a global public health problem and a new definition[J]. J Atheroscler Thromb, 2005, 12(6):295-300.
[29]	Yoo K B, Suh H J, Lee M, et al. Breakfast eating patterns and the metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2009[J]. Asia Pac J Clin Nutr, 2014, 23(1):128-137.
[30]	Hong S, Song Y, Lee K H, et al. A fruit and dairy dietary pattern is associated with a reduced risk of metabolic syndrome[J]. Metabolism, 2012, 61(6):883-890.
[31]	Praveen R P, Bhattacharya S, Saravana K S, et al. Do Bariatric Surgery-Related Type 2 Diabetes Remission Predictors Add Clinical Value? A Study on Asian Indian Obese Diabetics[J]. Obes Surg, 2017, 27(8):2113-2119.
[32]	Wang G F, Yan Y X, Xu N, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis[J]. Obes Surg, 2015, 25(2):199-208.
[33]	Cooper T C, Simmons E B, Webb K, et al. Trends in Weight Regain Following Roux-en-Y Gastric Bypass (RYGB) Bariatric Surgery[J]. Obes Surg, 2015, 25(8):1474-1481.
[34]	Golomb I, Ben D M, Glass A, et al. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy[J]. JAMA Surg, 2015, 150(11):1051-1057.
[35]	Paul L, van der Heiden C, Hoek H W. Cognitive behavioral therapy and predictors of weight loss in bariatric surgery patients[J]. Curr Opin Psychiatry, 2017, 30(6):474-479.
[36]	Puzziferri N, Roshek T R, Mayo H G, et al. Long-term follow-up after bariatric surgery: a systematic review[J]. JAMA, 2014, 312(9):934-942.

参数	术前	术后	P值
体重（kg）	103.22±32.3	78.5±22.5	<0.01
BMI（kg/m²）	36.1±8.3	27.5±5.7	<0.01
EWL%	?	70±31	?

参数	术前	术后	P值
体重（kg）	103.22±32.3	78.5±22.5	<0.01
BMI（kg/m²）	36.1±8.3	27.5±5.7	<0.01
EWL%	?	70±31	?

参数	效果极佳或良好（EWL%≥50%）	效果不足或无效（EWL%<50%）	P值
例数（例）	60	20	?
男性[%（例）]	41.7（25）	45.0（9）	0.794
年龄（岁）	37.85±11.29	40.45±11.40	0.376
T2DM[%（例）]	71.7（43）	70.0（14）	0.887
LRYGB[%（例）]	60.0（36）	65（13）	0.691
WHtR（%）	0.97±0.08	0.99±0.06	0.301
WHR（%）	0.66±0.10	0.75±0.11	0.001
BMI（kg/m²）	34.78±7.86	40.1±8.55	0.012

参数	效果极佳或良好（EWL%≥50%）	效果不足或无效（EWL%<50%）	P值
例数（例）	60	20	?
男性[%（例）]	41.7（25）	45.0（9）	0.794
年龄（岁）	37.85±11.29	40.45±11.40	0.376
T2DM[%（例）]	71.7（43）	70.0（14）	0.887
LRYGB[%（例）]	60.0（36）	65（13）	0.691
WHtR（%）	0.97±0.08	0.99±0.06	0.301
WHR（%）	0.66±0.10	0.75±0.11	0.001
BMI（kg/m²）	34.78±7.86	40.1±8.55	0.012

参数	OR值	P值
WHtR	0.000	0.021
BMI	1.125	0.173

Please choose a citation manager

Content to export